First granted example of novel FDA trial design under expedited access pathway for premarket approval: BeAT-HF

ConclusionThrough a unique collaboration with FDA under the EAP, the BeAT-HF trial design allows for the possibility of approval of BAT, initially for symptom relief and subsequently for outcomes improvement.

Source: American Heart Journal - July 22, 2018 Category: Cardiology Source Type: research